|
Goodwill and Other Intangible Assets (Details) (USD $)
In Millions, unless otherwise specified
|
3 Months Ended |
|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
Dec. 31, 2014
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Amortization of Intangible Assets |
$ 154.2 |
$ 131.9 |
|
| Finite-Lived Intangible Assets, Gross |
7,761.7 |
|
5,833.6 |
| Goodwill |
3,946.9 |
|
1,758.1 |
| Indefinite-Lived Intangible Assets, Gross |
4,242.6 |
|
1,769.5 |
| Finite-Lived Intangible Assets, Accumulated Amortization |
(3,109.7) |
|
(2,960.8) |
| Finite-Lived Intangible Assets, Net |
4,652.0 |
|
2,872.8 |
| Human Pharmaceutical Products [Member] |
|
|
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Goodwill |
1,359.1 |
|
1,359.4 |
| Animal Health Products [Member] |
|
|
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Goodwill |
2,587.8 |
|
398.7 |
| In Process Research and Development [Member] |
|
|
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Indefinite-Lived Intangible Assets (Excluding Goodwill) |
295.7 |
|
11.4 |
| Developed Technology Rights [Member] |
|
|
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Finite-Lived Intangible Assets, Gross |
7,614.3 |
|
5,684.3 |
| Finite-Lived Intangible Assets, Accumulated Amortization |
(3,062.0) |
|
(2,915.6) |
| Finite-Lived Intangible Assets, Net |
4,552.3 |
|
2,768.7 |
| Other Intangible Assets [Member] |
|
|
|
| Indefinite-lived Intangible Assets [Line Items] |
|
|
|
| Finite-Lived Intangible Assets, Gross |
147.4 |
|
149.3 |
| Finite-Lived Intangible Assets, Accumulated Amortization |
(47.7) |
|
(45.2) |
| Finite-Lived Intangible Assets, Net |
$ 99.7 |
|
$ 104.1 |